Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06030700 · ClinicalTrials.gov registry record

FoodImage 3 Laboratory

A clinical trial, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
25
Enrollment target

NCT06030700: Completed study, sponsored by Pennington Biomedical Research Center.

NCT06030700 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06030700 has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
25 participants
Enrollment target

Study Summary

The Laboratory Study will be conducted at PBRC and will include participants (N=25) from a wide array of social and economic groups will be recruited and trained on the use of the FoodImage app. Participants use the app to measure food waste (including foods with inedible parts) created during a simulated meal preparation setting, a simulated meal consumption setting with plate waste, and a simulated cabinet and refrigerator clean-out of spoiled and out-of-date foods, where the number of items and the amounts of waste for each task is randomly assigned across participants and blinded from the research staff evaluating images and coding data. These participants will denote the normal discard destination (I.e., garbage, sink/disposal, feed to animal, compost) for each item as if the waste had occurred in their own home.

Primary Outcome

Weight (g)

Interventions

  • OTHER Controlled Conditions

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-01-10
Est. Completion 2025-02-06

What the finished NCT06030700 record still lists

NCT06030700 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Controlled Conditions is the first listed.

NCT06030700 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06030700 about?

NCT06030700 is a clinical study titled "FoodImage 3 Laboratory". The Laboratory Study will be conducted at PBRC and will include participants (N=25) from a wide array of social and economic groups will be recruited and trained on the use of the FoodImage app. Participants use the app to measure food waste (including foods with inedible parts) created during a sim...

What is the current status of trial NCT06030700?

This trial is currently completed. The enrollment target is 25 participants. The study started on 2024-01-10. Estimated completion is 2025-02-06.

What interventions are being tested in trial NCT06030700?

The interventions under investigation include: Controlled Conditions (OTHER).

Who is sponsoring clinical trial NCT06030700?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06030700, the US trial registry maintained by the National Library of Medicine. NCT06030700 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.